Investigating warning labels on little cigars and cigarillos to reduce tobacco-related cancers
Little Cigar and Cigarillo Warnings to Reduce Tobacco-Related Cancers and Disease
This study is looking at how different warning labels on little cigars and cigarillos can help adults use them less, and it also checks if taking away flavor names from the packaging makes the warnings more effective.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10690621 on NIH RePORTER |
What this research studies
This research focuses on understanding how warning labels on little cigars and cigarillos can be designed to effectively reduce their use among adults. It examines various characteristics of these warnings, such as content, format, and size, to determine which are most impactful. The study also explores the effects of removing flavor descriptors from packaging, which may enhance the effectiveness of the warnings. By analyzing these factors, the research aims to provide insights that could lead to better public health policies regarding tobacco products.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults who currently use little cigars or cigarillos.
Not a fit: Patients who do not use little cigars or cigarillos or who are under 21 years old may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective warning labels that reduce the use of little cigars and cigarillos, ultimately decreasing tobacco-related cancers.
How similar studies have performed: Previous research on cigarette warning labels has shown success in reducing smoking rates, suggesting that similar approaches may be effective for little cigars and cigarillos.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Goldstein, Adam O — Univ of North Carolina Chapel Hill
- Study coordinator: Goldstein, Adam O
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.